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A B S T R A C T
Purpose: Behcet disease (BD) is a chronic relapsing inﬂammatory disorder. Neuro BD (NBD) is seen in
approximately 5% of all patients. The aim of this study is to investigate the frequency, type and prognosis
of epileptic seizures in different forms of NBD.
Methods: All ﬁles of 42 patients with NBD were evaluated between 2006 and 2012, retrospectively. The
demographic data, the presentation of NBD, clinical ﬁndings including seizures, EEG and neuroimaging
ﬁndings were reviewed.
Results: The mean age of patients was 35.02  8.43 years. Thirty (71.4%) patients were male; the remaining
12 of them were female. Twenty-four patients had brainstem lesions; 16 patients had cerebral venous
thrombosis. Spinal cord involvement was seen in two patients. Seven patients had epileptic seizures (six
partial onset seizures with or without secondary generalization). Six of them had cerebral sinus thrombosis
(CVT). Four patients had a seizure as the ﬁrst symptom of the thrombosis. One patient had late onset seizure
due to chronic venous infarct. The other patient with seizure had brainstem involvement. The remaining was
diagnosed as epilepsy before the determination of NBD.
Conclusion: CVT seen in BD seems to be the main risk factor for epileptic seizures in patients with NBD.
The prognosis is usually good especially in patients with CVT. Epileptic seizures in patients with
brainstem involvement may be an indicator for poor prognosis. Superior sagittal thrombosis or cortical
infarct would be predictor of seizures occurrence because of the high ratio in patients with seizures.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Behcet’s disease (BD) is a chronic relapsing inﬂammatory disease
of unknown etiopathogenesis [1–3]. It is a disorder of young adults
with male predominance. There is a geographical variation in
prevalence [4]. Hulusi Behcet, Turkish dermatologist, ﬁrst described
it [2]. BD is mainly characterized by oral and genital ulcerations,
ocular manifestations and by involvement of the gastrointestinal,
cardiovascular, pulmonary, skeletal and central nervous system
[1]. Recurrent oral ulceration is prerequisite with any two of genital
ulcerations, skin lesions, uveitis and hyperactivity of skin to
nonspeciﬁc physical insult (Patergy test) according to the diagnostic
criteria formed by the International Study Group [5].* Corresponding author at: Mugla Sitki Kocman Universitesi Tip Fakultesi,
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reNeurologic manifestation in BD (NBD) is involved in about
5–10% of the patients with BD [3,6]. There are two major forms of
neurologic involvement of BD according to the clinical and imaging
examination. The ﬁrst, which is seen in the majority of patients,
may be characterized as a vascular-inﬂammatory central nervous
system (CNS) disease with focal or multifocal parenchymal
involvement, mostly presenting with a brainstem syndrome
(intra-axial NBD); the other, which has few symptoms and a
better neurologic prognosis, may be caused by isolated cerebral
venous sinus thrombosis and intracranial hypertension (extra-
axial NBD), occurring in up to 20% of the cases. Spinal cord
involvement, arterial CNS involvement, optic neuritis, aseptic
meningitis, and peripheral neuropathies may be seen as a
presentation of NBD, but are rare [3,7].
Epileptic seizure in NBD was observed rarely in previous studies
[8,9] Different seizures types such as partial seizures, generalized
tonic clonic seizures; myoclonic jerks, epilepsia partialis continua
and status epilepticus were reported [8–12]. The aim of this study
is to investigate the frequency, type and prognosis of epileptic
seizures in different forms of NBD.served.
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All ﬁles of 42 patients with NBD were reviewed retrospectively
in Ankara Research and Training Hospital, Department of
Neurology between January 2006 and December 2012, retrospec-
tively. The demographic data, the presentation of NBD, clinical
ﬁndings including seizures, cerebrospinal ﬂuid (CSF) examination,
electroencephalography (EEG) and neuroimaging ﬁnding were
reviewed. Seizures were classiﬁed according to the criteria of
International League Against Epilepsy [13]. The diagnosis of NBD
was revised according to the International Consensus Recommen-
dation (ICR) Criteria for NBD during the retrospective analysis
[14]. The clinical course of epileptic seizures and NBD were also
evaluated.
3. Results
The mean age of patients was 35.02  8.43 years. Thirty (71.4%)
patients were male; the remaining twelve (28.6%) of them were
female. All of the patients had deﬁnite NBD according to the ICR
criteria. Twenty-four (57.1%) patients with NBD had CNS parenchy-
mal involvement with brainstem-diencephalic regions. CVT was
present in sixteen (38.1%) while two patients had only spinal cord
involvement (5.8%).
Seizures were observed in seven (16.7%) of 42 patients.
Demographic data, clinical features, seizure type, CSF ﬁndings,
EEG, magnetic resonance imaging ﬁndings and prognosis are
shown in Table 1. The mean age was 30.43  9.36 years (age range
24–49). Only one patient with seizure was female, the remaining six
(85.7%) patients were male. Mean age at the diagnosis of BD
27.0  8.68 (16–42 years) years. The patients with epileptic seizures
were followed up between 3 months and 5.5 years (mean:
32.14  22.37 months). In their medical history, six patients had
no risk factors regarding the epilepsy; only one patient had the family
history for epilepsy. The mean duration of NBD in patients without
seizures was 30.34  22.24 months.
CVT was observed in six patients with epileptic seizure. Cranial
magnetic resonance imaging and venography was performed to allTable 1
Demographic data, clinical features, seizure type, CSF ﬁndings, EEG, magnetic resonanc
No Age
year
Sex AgeDx
BD year
NBD
type
Relation
NBD
Seizure
type
CSF 
1 25 M 24 CVT Attack Partial onset – 
SGTCS 
2 37 M 35 CVT Attack Partial onset – 
SGTCS 
3 24 M 22 CVT Attack Partial onset – 
4 28 M 25 CVT Attack Partial onset – 
SGTCS 
5 26 F 25 CVT Course Partial
onset SE
High Pro 
Pro: 68 mg/dl 
Mild 
Pleocytosis 
6 24 M 16 CVT Before Myoclonic – 
Attack GTCS 
7 49 M 42 Brain
stem
lesion
Course Partial
onset
High pro Pro:
89 mg/dl
Moderate
Pleocytosis
BD, Behcet disease; NBD, Neuro-Behcet disease; CSF, cerebrospinal ﬂuid; CVT, cereb
generalized tonic clonic seizure; act, activity; SSS, superior sagittal sinus; TS, transver
magnetic resonance venography; HH, hemi-hypoesthesia; AED, antiepileptic drug; JMEpatients. Superior sagittal thrombosis was present in four patients
(66.7%) while two patients had left transverse sinus thrombosis
(Fig. 1A and B). However, the ratio of superior sagittal thrombosis
was 40% when the patients diagnosed as CVT without seizures
were analyzed.
Among the patients with CVT, ﬁve of them had complex partial
seizures and three of them had also secondary generalized tonic
clonic seizures (SGTCS). Four patients had seizures as the ﬁrst
symptom of the thrombosis. One patient had late onset seizure
probably due to chronic venous infarction in left temporal–parietal
region seven weeks after the diagnosis of NBD disease. The seizures
of other patient were started three months before the determina-
tion of thrombosis.
Patient 1 and 2 had only one partial onset and SGTCS seizure at
admission. They were treated with carbamazepine and levetir-
acetam, respectively and antiepileptic drugs were stopped 6 and
8 months of treatment. No seizure was seen in their follow up.
Their EEGs were also normal. Patient 3 had two complex partial
seizures, whereas three partial onset and SGTCS was present in
Patient 4. They were treated oxcarbazepine and carbamazepine
during 24 months, respectively. The dose of antiepileptic drug was
decreased in Patient 3 and 4 and termination of treatment is
planned for them. 4–7 Hz slow waves were seen in their ﬁrst EEG
and recurrent EEG examinations were normal. Seizure was not
recurred in both of patients. Patient 5 (only female patient) had
venous infarction and she was admitted to the hospital with
complex partial status epilepticus seven weeks after the diagnosis
of CVT. Left temporal seizure activity was also observed in her EEG.
Firstly, phenytoin infusion was applied to her and then phenytoin
therapy was continued. She was followed up during 66 months
after the seizure. The treatment was changed from phenytoin to
oxcarbazepine, because she was planning pregnancy. No seizure
was occurred before, during and after pregnancy. We decided to
terminate the treatment after 52 months from the seizure
beginning and decreased the dosage. However, complex partial
seizure was started again and the dosage was increased. Recurrent
EEG also showed us left temporal sharp waves (Fig. 2). Myoclonic
and one generalized tonic clonic seizure (GTCS) were present ine imaging ﬁndings and prognosis of patients.
Clinical
manifestation
EEG MRI MRV Follow
up
month
Outcome
Headache 1.N SSS 35 Seizure free
Papilledema 2. N Thrombosis AED stopped
Headache 1.N SSS 12 Seizure free
Papilledema 2. N Thrombosis AED stopped
Headache 1. Slow waves SSS 24 Seizure free
Papilledema 2. N Thrombosis AED continue
3.N Termination plan
Headache 1. Slow waves TS 30 Seizure free
Papilledema 2. N Thrombosis AED continue
termination plan
RHH 1. Seizure act TS 66 Seizure free
Papilledema 2. L T Sharp w Thrombosis Recurrence when
3.LTSharpw Venous AED decrease
4. L T Sharp w Infarct Seizure free
with treatment
Headache 1. Spike wave SSS 55 Rare myocloni
2. Spike wave Thrombosis AED continue
3. Spike Wave
Hemiparesis
decrease
consciousness
1. Slow waves Brain Stem
lesion
3 Seizure free Died
ral sinus thrombosis; SGTCS, secondary generalized tonic clonic seizure; GTCS,
se sinus; EEG, electroencephalography; MRI, magnetic resonance imaging; MRV,
, juvenile myoclonic epilepsy; Dx, diagnosis; SE, status epilepticus; Pro, protein.
Fig. 2. Left tempora
Fig. 1. (A) and (B) Left transverse sinus thrombosis in magnetic resonance
venography.
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of CVT. During 55 months of follow up, rare myoclonic jerks were
occurred under the treatment of valproic acid. Multiple spikes and
poly-spikes were seen in his EEGs. In the medical history, his grand
mother had also epilepsy, however we do not have any information
about the type of seizures.
The remaining patient with epileptic seizure (Patient 7) had
CNS parenchymal involvement. Cranial magnetic resonance
imaging revealed a lesion in brainstem especially mesencephalic
region and it ascended to both thalamus. The progression of BD
was very aggressive for this patient. Many systemic such as
pulmonary system and gastrointestinal system involvement were
also seen besides NBD. Complex partial seizures were started one
month after the diagnosis of brainstem lesion. CSF examination
revealed high protein content and moderate pleocytosis. He was
intubated because of pulmonary involvement and died after three
months. Levetiracetam was started after two complex seizures and
no seizure was observed with this treatment during short follow
up period. EEG showed only slow waves.
4. Discussion
In our study, seizures (16.7%) were seen more frequently from
previous study. Aykutlu et al. found that 10 (4.48%) of 223 patients
with BD had seizures [9]. The larger number of CVT patients might
cause the higher ratio in our group. In this study, CVT was
diagnosed in six patients whereas brainstem parenchymal lesion
was present in only one patient. Seizures were the ﬁrst
presentation of the CVT in four patients. The prognosis of these
patients was very good in terms of epileptic seizures and NBD. CVT
is one of the major neurological presentations of NBD [15]. The
main clinical signs of CVT were headache, seizures, and focal
neurological signs, papilledema, and decreased level of conscious-
ness [16,17]. In our patients, four of them had headache and
papilledema besides the seizures. Patient with late onset seizures
had papilledema and right hemi-hypoesthesia in the acute
presentation of the CVT. Patient with seizures before the diagnosis
of NBD had only severe headache. Good prognosis was reported for
BD patients with CVT like our patients [18]. The antiepileptic
treatment was stopped in two patients while we decided to
terminate the treatment in other two patients. They did not have
any seizure during their follow up. The treatment could not bel sharp waves.
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recurrence, so the duration of treatment must be longer in
patients with cortical lesions. The remaining patient, who had
seizures before the diagnosis of NBD, described myoclonic jerks
and GTCS and multiple spikes and poly-spikes were observed in his
EEGs. This EEG ﬁnding and clinical presentation could be observed
both myoclonic epilepsy and frontal lobe epilepsy, so differential
diagnosis cannot be done. The treatment was continued because of
his rare jerks.
The patients with brainstem lesion had complex partial seizures
during the course of NBD. The seizure was begun one month after
the diagnosis of NBD. CSF examination showed elevated protein
level and pleocytosis. The BD duration was 84 months, however,
not only NBD but also systemic presentation of BD had also rapid
progression in especially last 4 months. He was died 3 months after
the seizure beginning probably due to pulmonary involvement of
BD. His seizures were completely controlled by levetiracetam.
Previously, NBD has a high rate of mortality about 10% [6]. In
another report, four patients were deceased among 10 NBD
patients with seizures [9]. According to these studies and our
study, brainstem involvement together with seizure occurrence
may be predictor of poor prognosis and may cause high mortality
rates. New studies should be designed to enlighten this hypothesis.
All patient had EEG examination. Sixteen routine EEG and one
sleep EEG was performed to the patients. Two patients had normal
EEG in their follow up. EEG revealed slow waves at the beginning
(they may be postictal EEG) in other two patients and recurrent
EEG for them were also normal. Antiepileptic drug treatment was
stopped in two of them with normal EEG and the treatment
termination was planned in the other two. They all seizure free
during follow up, so normal EEG is a supporting ﬁndings of the
good prognosis for seizures. EEG of the patient with venous infarct
had ictal activity at the admission. Left temporal sharp waves were
present in all EEG after the control of status epilepticus. We cannot
stop the treatment for epilepsy in this patient because of seizure
recurrence. Two routine EEG and one sleep EEG was applied to the
patients with seizures before the diagnosis of NBD. All EEG showed
us multiple spike and poly-spike waves. Matsumoto found that the
EEG changes seemed to be well correlated with the clinical
symptoms [19]. We also found the correlation between the seizure
prognosis and EEG. Another study described a patient with a
progressive NBD whose initial EEG showed periodic lateralized
epileptiform discharges (PLEDs) [20]. PLEDs were not observed
in EEGs of our cases including the patients with aggressive
presentation.
Status epilepticus is very rarely seen in NBD. The case of
epilepsia partialis continua and recurrent status epilepticus were
reported from Turkey [9,10], previously. In our study, one patient
had complex partial status epilepticus seven weeks after the
diagnosis of CVT.
The cause of seizures mainly might be due to the increased
intracranial pressure rather than the neuro-inﬂammatory changes.
One patient also had cerebral cortical venous infarction and the
seizures of this patient mainly due to the lesion. Superior sagittal
sinus thrombosis was observed in four patients with (4/6–66.7%
versus patients without seizure 4/10–40%), whereas only two
patients had transverse sinus thrombosis, one of them had also
cortical infarct. Superior sagittal sinus thrombosis ratio was high
(4/6–66.6%) in patients with seizures when we compared them
patients without seizures (4/10–40%). One of the patients with
transverse sinus thrombosis had also cortical infarct and no
cortical infarction was detected in patients without seizures. Wethought that superior sagittal thrombosis or cortical infarct would
be predictor of seizures occurrence because of the high ratio in
patients with seizures.
5. Conclusion
CVT seen in BD seems to be the main risk factor for epileptic
seizures in patients with NBD. The prognosis is usually good
especially in the patients with CVT. Epileptic seizures in patients
with brainstem involvement may be an indicator for poor
prognosis. Superior sagittal thrombosis or cortical infarct would
be predictor of seizures occurrence because of the high ratio in
patients with seizures. Therefore multi-centric studies, which
were containing large number of patients, are necessary to
evaluate association between NBD, localization of CVT and
epileptic seizures type and frequency, status epilepticus, EEG,
and prognosis.
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